glp-1 receptor agonist drugs in development research Market Size Emerging Trends in the Development

10.1172/JCI140695 73 MizumuraK.JusticeM

GLP-1 treatment can exert the direct action on reversing vascular remodeling by downregulating MMP1 expression via alleviating the ERK1/2/NF-B pathway in Ang II-induced rat aortic VSMCs [130]

The Company has incurred recurring losses since inception and as of December 31, 2023, had an accumulated deficit of approximately $ The source, timing and availability of any future financing will depend principally upon market conditions, and, more specifically, on the progress of the Companys clinical development programs

For a 10 mg vial, mix with 3.0 mL of solvent for a concentration of 3.33 mg/mL